Single‐nucleotide polymorphism‐based chromosomal microarray analysis provides clues and insights into disease mechanisms. (5th November 2019)

• Record Type: Journal Article
• Authors: Daum, H.; Meiner, V.; Hacohen, N.; Zvi, N.; Eilat, A.; Drai‐Hasid, R.; Yagel, S.; Zenvirt, S.; Frumkin, A.
• Is Part Of: Ultrasound in obstetrics & gynecology. Volume 54:Number 5(2019)
• Page Start: 655
• Page End: 660
• Publication Date: 2019-11-05
• Subjects: absence of heterozygosity -- biochemical screening test -- CMA -- fetal malformation -- imprinting disorder -- Kagami–Ogata syndrome -- maternal serum analyte -- monogenic disease -- prenatal diagnosis -- runs of homozygosity -- uniparental disomy; Ultrasonics in obstetrics -- Periodicals; Generative organs, Female -- Diseases -- Diagnosis -- Periodicals; Diagnosis, Ultrasonic -- Periodicals; Genital Diseases, Female -- ultrasonography -- Periodicals; Ultrasonography, Prenatal -- Periodicals; 618.047543
• DOI: 10.1002/uog.20230
• Languages: English
• ISSNs: 0960-7692

Abstract

ABSTRACT: Objective: Chromosomal microarray analysis (CMA) is the modality of choice for prenatal diagnosis in pregnancy with fetal malformation, as it has a high diagnostic yield for microdeletion/duplication syndromes. The aim of this study was to demonstrate the additional utility of single‐nucleotide polymorphism (SNP)‐based CMA in diagnosing monogenic diseases, imprinting disorders and uniparental disomy (UPD). Methods: CMA was performed using Affymetrix CytoScan array, for all indications in 6995 pregnancies, at a tertiary referral hospital from November 2013 to June 2018. We describe four cases that had a CMA result that provided a more comprehensive understanding of the complex genetic mechanisms underlying the clinical presentation. Results: In the first fetus, CMA was performed due to intrauterine growth restriction and revealed a 75 kbp maternally inherited microdeletion encompassing the Bloom syndrome gene ( BLM ). A diagnosis of Bloom syndrome was made upon identifying a paternally inherited common Ashkenazi founder mutation. In the second case, CMA was performed due to severely abnormal maternal serum analytes and revealed a deletion in 14q32.2q32.31 on the maternally inherited copy, leading to a diagnosis of Kagami–Ogata syndrome, which is an imprinting disorder. In the third case, amniocentesis was performed because of late‐onset fetal macrosomia and mild polyhydramnios. CMA detected a deletion encompassing the locus of Prader–Willi/Angelman syndrome. In the fourth case, amniocentesis was performed due to maternal cytomegalovirus seroconversion. Maternal UPD of the entire long arm of chromosome 11 was detected. Conclusion: Prenatal CMA, based on oligo and SNP platforms, increases the diagnostic yield and enables a wider spectrum of disorders to be detected through the identification of complex genetic etiologies beyond only copy number variants. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.